(800)525-7111 Free Consultation

Zantac Esophageal Cancer Risk

Riddle Brantley LLP   |  April 23, 2020   |  

Have you been diagnosed with esophageal cancer after taking Zantac or generic ranitidine medication for heartburn? There may be Zantac esophageal cancer risk. Here’s what you need to know to protect yourself and your loved ones and see if you qualify for a Zantac cancer claim.

Background: NDMA Contamination in Zantac

The FDA has reported that Zantac and ranitidine medications are contaminated with elevated levels of NDMA. NDMA is a cancer-causing chemical that is naturally occurring in certain foods and water, but can be extremely dangerous at higher levels.

NDMA is actually used to cause cancer in laboratory animals, and there may be esophageal cancer and other cancer risk associated with contaminated Zantac.

Does Zantac cause esophageal cancer?

Many who have taken Zantac or ranitidine are concerned about the potential risk of esophageal cancer based on the FDA’s report on NDMA contamination in these common medications. Many cancers have been tentatively linked to Zantac, including esophageal cancer and other digestive tract cancers.

Researchers are working to further identify potential cancers associated with NDMA-contaminated Zantac, but in the interim, here’s what we know about Zantac esophageal cancer risk:

Scientific Evidence of Esophageal Cancer Risk from NDMA Exposure

Zantac Esophageal Cancer Risk - Digestive Tract CancersIn a 2016 study on digestive tract cancers’ association with NDMA exposure, researchers determined that “NDMA had significant positive effect on the incidence of digestive tract cancers.” Esophageal cancer is a digestive tract cancer and may be caused by NDMA contamination in Zantac.

Although the study did not find a statistically significant causal relationship between NDMA exposure and esophageal cancer specifically, growing evidence indicates that Zantac esophageal cancer risk may be real.

A separate study that examined rats’ ingestion of NDMA also did not find statistically significant evidence of a casual relationship between the chemical and esophageal cancer, but more research must be done in order to rule out the relationship completely.

In the meantime, those who have taken Zantac or ranitidine should be aware that there may be Zantac esophageal cancer risk.

Have you taken Zantac and been diagnosed with esophageal cancer (or another type of cancer)?

Zantac NDMA contamination has been tentatively linked to many cancers, including esophageal cancer:

If you’ve taken Zantac or ranitidine for more than 6 months and been diagnosed with esophageal cancer or any of the cancers listed above, you may have a Zantac cancer claim and you may be entitled to compensation.

Esophageal Cancer Claim for Zantac - Riddle & BrantleyOur experienced Zantac cancer attorneys may be able to help.

For a FREE, no-obligation consultation with a Zantac lawsuit lawyer, please call 1-800-525-7111 or complete the short form below. There are no upfront costs and no attorney fees unless we win your case and you receive financial compensation.

At Riddle & Brantley, our attorneys have nearly 200 years of combined legal experience and have been fighting to hold drug companies accountable since 1985.

We’re proud of the record of settlements and judgments we’ve secured on behalf of our clients, and are humbled by the words our clients use to describe working with us:

“I would recommend them to anyone. They fought hard for me.”

-Christine W., Riddle & Brantley client

If you’ve taken Zantac and been diagnosed with esophageal cancer or any of the cancers listed above, please call 1-800-525-7111 for a FREE consultation.

You deserve justice and may be entitled to financial compensation.

“We believe Justice Counts for those injured potentially due to Zantac and are committed to holding drug companies accountable.”

-Gene Riddle, managing partner and attorney, Riddle & Brantley

You don’t have to do this alone. Our Zantac lawyers are ready to help. Please contact us today.

 

*** Disclaimer: The results mentioned are intended to illustrate the type of cases handled by the firm. These results do not guarantee a similar outcome, and they should not be construed to constitute a promise or guarantee of a particular result in any particular case. Every case is different, and the outcome of any case depends upon a variety of factors unique to that case.